期刊文献+

硫胺素对实验性铅性肾病的治疗作用及其对纤维连接蛋白表达的影响 被引量:1

Effect of thiamine on prevention of experimental lead nephropathy and expression of fibronectin
下载PDF
导出
摘要 目的观察硫胺素对铅性肾病的治疗作用,并从蛋白质和分子水平观察其对纤维连接蛋白(FN)表达的影响。方法SD大鼠72只适应性饲养1周,随机分为3组:正常对照组、染铅组、硫胺素组,每组又根据喂饮时间的不同分3个亚组。正常对照组予蒸馏水喂饮;染铅组给予0.5%的醋酸铅喂饮;硫胺素组在给予0.5%的醋酸铅喂饮的同时予硫胺素3mg/100g体重,注射用水稀释、灌胃每天一次。各组分别喂饮1,2,3个月。然后用原子吸收光谱石墨炉法测血铅含量;用热消化法测肾铅含量;用免疫组化的方法检测肾组织FN蛋白的表达,用RT-PCR的方法检测肾组织FN mRNA的表达。结果硫胺素组喂饮3个月后,大鼠血铅含量较染铅组显著下降。硫胺素组喂饮2个月后,大鼠肾铅含量较染铅组也明显降低。与染铅组比较,硫胺素组肾组织FN蛋白的表达在喂饮3个月后显著下降,而mRNA的表达在喂饮2个月后即显著下降。结论硫胺素不仅有驱铅的作用,对铅所导致的肾脏纤维化也有一定的保护作用。 Objective To investigate the preventive effect of thiamine on experimental lead nephropathy, and its influence on the expression of fibronectin in kidney at molecular levels. Methods Seventy-two SD rats weighing 180 - 220 g were randomly assigned into three groups:control group, Pb group and Vb group. The rats in control group were given distilled water for 1,2,3 months respectively, the rats in Pb group were given 0.5 % lead acetate water for 1,2,3 months respectively, and the rats in Vb group were simultaneously given 0.5% lead acetate water and thiamine 3 mg/100 g body weight by intragastric administration for 1,2,3 months respectively. All rats were sacrificed at the end of the treatment. Lead concentrations in blood and kidney were determined by graphite furnace atomic absorption spectrometry. Expression of FN protein and mRNA in kidney was measured by immunohistochemistry and RT-PCR, respectively. Results Compared with Pb group, kidney lead concentrations decreased significantly after administration for 2 months in Vb group, and blood lead concentrations also decreased after administration for 3 months. The expression of FN protein was significantly lower in Vb group than in Pb group after administration for 3 months,while the expression of FN mRNA veas significantly lower in Vb group than in Pb group after administration for 2 months. Conclusion Thiamine can not only prevent accumulation of lead in the body, but also protect the lead-induced renal fibrosis.
出处 《山西医科大学学报》 CAS 2009年第11期969-972,1055,共5页 Journal of Shanxi Medical University
基金 山西医科大学博士启动基金资助项目(055066)
关键词 硫胺素 铅性肾病 纤维连接蛋白 thiamine lead nephropathy fibronectin
  • 相关文献

参考文献14

  • 1Kalia K, Flora SJ. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning [ J ]. J Occup Health ,2005,47 ( 1 ) : 1 - 21.
  • 2Bratton GR, Zmudzki J, Kincaid N ,et al. Thiamin as treatment of lead poisoning in ruminants [ J ]. Mod Vet Pract, 1981,62 ( 6 ) : 441 -446.
  • 3蒋云生,夏运成,徐锡萍,罗季安.碘化钾和硫胺素抗铅性肾损害效果观察[J].中华预防医学杂志,1997,31(4):252-253. 被引量:8
  • 4Gidlow DA. Lead toxicity [J]. Occup Med, 2004,54 ( 2 ) : 76 - 78.
  • 5Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases:a four-year prospective longitudinal study [J]. J Am Soc Nephrol,2004,15 (4) : 1016 - 1022.
  • 6Mahmoud LA. Renal effects of environmental and occupational lead exposure [J]. Environ Health Perspect, 1997, 105 ( 9 ) : 928 - 938.
  • 7Wang VS, Lee MT, Chiou JY, et al, Relationship between blood lead levels and renal function in lead battery workers [ J ]. Int Arch Occup Environ Health ,2002,75 ( 8 ) :569 - 575.
  • 8Ehrlich R, Robins T, Jordaan E, et al. Lead absorption and renal dysfunction in a South African battery factory[J]. Occup Environ Med, 1998,55 (7) :453 - 460.
  • 9Roels H, Lauwerys R, Konings J, et al. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead [ J]. Occup Environ Med, 1994,51 (8) :505 - 512.
  • 10Campbell C, Osterhoudt KC. Prevention of childhood lead poisoning[ J ]. Curr Opin Pediatr,2000,12:428 - 437.

二级参考文献13

  • 1蒋云生,刘瑞洪.驱铅疗法在铅性肾病中的作用[J].中华肾脏病杂志,1993,9(6):350-352. 被引量:3
  • 2蒋云生,徐锡萍,刘瑞洪,罗季安,袁曙光,夏运成,赵克凤,李五书.慢性铅性肾病的肾脏病理[J].湖南医科大学学报,1994,19(6):527-530. 被引量:10
  • 3Eismann U,Sommer M,Kosmehl H,et al.Fibronectin splice variantsprognostic markers for the stage of renal interstitial fibrosis in the rat.Nephron,2002,92:379-388.
  • 4Brewster UC,Perazella NA.A review of chronic lead intoxication:an unrecognized cause of chronic kidney disease.Am J Med Sci,2004,327:341-347.
  • 5Graziano J,Slavkovich V,Liu X,et al.A prospective study of prenatal and childhood lead exposure and erythropoietin production.J Occup Environ Med,2004,46:924-929.
  • 6Inglis JA,Henderson DA,Emmerson BT.The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland.J Pathol,1978,124:65-76.
  • 7Ramesh GT,Manna SK,Aggarwal BB,et al.Lead activates nuclear transcription factor-kappaB,activator protein-1,and amino-terminal c-jun kinase in pheochromocytoma cells.Toxicol Appl Pharmacol,1999,155:280-286.
  • 8Fowler BA.Roles of lead-binding proteins in mediating lead bioavailability.Environ Health Perspect,1998,106(Suppl):1585-1587.
  • 9熊敏如.铅性肾病防治研究概况[J].职业医学,1998,25(3):46-48. 被引量:14
  • 10谢万力,黄建勋,李来玉.铅预防性投药的研究进展[J].职业医学,1998,25(3):48-49. 被引量:12

共引文献13

同被引文献38

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部